.jpg)
Cantor Fitzgerald analyst Craig Bijou reiterated a Buy rating on Wright Medical Group (NASDAQ: WMGI) today and set a price target of $30. The company’s shares closed on Friday at $20, close to its 52-week low of $19.04.
Bijou said:
“We track WMGI’s Augment’s global LTM (last twelve months) sales, which are posted to the company’s investor relation’s website each month.”
According to TipRanks.com, Bijou is a 4-star analyst with an average return of 22.0% and a 57.9% success rate. Bijou covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Integra Lifesciences, and Stryker Corporation.
Wright Medical Group has an analyst consensus of Strong Buy, with a price target consensus of $27.
See today’s analyst top recommended stocks >>
The company has a one-year high of $30.59 and a one-year low of $19.04. Currently, Wright Medical Group has an average volume of 1.08M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Wright Medical Group NV is a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes. The company was founded by Frank O. Wright in 1950 and is headquartered in Arlington, TN.
